Canine Cancer (Small Breeds)

Gain a deeper understanding of Canine Cancer in Small Breeds through this focused and informative presentation by Prof. Dr. Mike Chan, created for veterinary professionals, animal health researchers, and devoted pet owners. The session explores the unique cancer risks in smaller dogs, from genetic predispositions to environmental influences, and outlines key warning signs that warrant prompt attention. It also covers the latest diagnostic methods, including advanced imaging, cytology, histopathology, and molecular profiling, to ensure accurate assessment. Treatment strategies are presented in a truly integrative framework, combining established interventions—such as precision surgery, chemotherapy, and targeted drug therapy—with cutting-edge regenerative modalities like PSC (Precursor Stem Cell Therapy), FOP (Frozen Organo Peptides), FOC (Frozen Organo Cryogenics), and TopPetPro innovations including MITO Peptide Organotherapy, NANO Peptide Organotherapy, etc. This comprehensive approach empowers early detection, personalised care, and improved long-term wellbeing for small-breed dogs facing cancer.